Immunovant Inc (IMVT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action
Code mnémonique : IMVT Marché : NAS


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2025-04-17 2025-04-16 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
1 000 -0.7%
14,89
44 566 USD 		1 000 -0.7% 14,89 100 000 USD
2025-04-17 2025-04-16 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
1 000 -0.7%
14,89
123 900 USD 		1 000 -0.7% 14,89 100 000 USD
2025-04-11 2025-04-09 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
1 000 -1.0%
12,99
52 610 USD 		1 000 -1.0% 12,99 100 000 USD
2025-04-11 2025-04-09 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
1 000 -1.7%
12,99
91 099 USD 		1 000 -1.7% 12,99 100 000 USD
2025-04-11 2025-04-09 V Vente

Geffner Michael

Chief Medical Officer

Dirigeant
1 000 -2.6%
12,99
80 135 USD 		1 000 -2.6% 12,99 100 000 USD
2025-04-11 2025-04-09 V Vente

Stout Jay S

Chief Technology Officer

Dirigeant
1 000 -2.3%
12,99
65 002 USD 		1 000 -2.3% 12,99 100 000 USD
2025-04-11 2025-04-09 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
1 000 -2.3%
12,99
364 941 USD 		1 000 -2.3% 12,99 100 000 USD
2025-03-11 2025-03-07 VP Vente planifiée

Fromkin Andrew J.

Administrateur non-exécutif
1 384 -1.5%
19,96
27 625 USD 		1 384 -1.5% 19,96 27 625 USD
2025-03-11 2025-03-07 VP Vente planifiée

Fromkin Andrew J.

Administrateur non-exécutif
6 616 -6.6%
19,52
129 144 USD 		6 616 -6.6% 19,52 129 144 USD
2025-02-21 2025-02-19 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
15 439 -1.6%
20,86
322 058 USD 		15 439 -1.6% 20,86 322 058 USD
2025-02-21 2025-02-19 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
2 055 -0.6%
20,86
42 867 USD 		2 055 -0.6% 20,86 42 867 USD
2025-02-21 2025-02-19 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
2 814 -0.9%
20,86
58 700 USD 		2 814 -0.9% 20,86 58 700 USD
2025-01-24 2025-01-22 V Vente

Geffner Michael

Chief Medical Officer

Dirigeant
2 657 -2.0%
23,59
62 679 USD 		2 657 -2.0% 23,59 62 679 USD
2025-01-24 2025-01-22 V Vente

Stout Jay S

Chief Technology Officer

Dirigeant
2 195 -1.5%
23,59
51 780 USD 		2 195 -1.5% 23,59 51 780 USD
2025-01-17 2025-01-15 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
415 -0.0%
24,19
10 039 USD 		415 -0.0% 24,19 10 039 USD
2025-01-17 2025-01-15 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
8 352 -0.9%
23,81
198 861 USD 		8 352 -0.9% 23,81 198 861 USD
2025-01-17 2025-01-15 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
109 -0.0%
24,19
2 637 USD 		109 -0.0% 24,19 2 637 USD
2025-01-17 2025-01-15 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
2 189 -0.7%
23,81
52 120 USD 		2 189 -0.7% 23,81 52 120 USD
2025-01-17 2025-01-15 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
19 -0.0%
24,19
460 USD 		19 -0.0% 24,19 460 USD
2025-01-17 2025-01-15 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
387 -0.1%
23,81
9 214 USD 		387 -0.1% 23,81 9 214 USD
2025-01-17 2025-01-15 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
94 -0.0%
24,19
2 274 USD 		94 -0.0% 24,19 2 274 USD
2025-01-17 2025-01-15 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
1 883 -0.5%
23,81
44 834 USD 		1 883 -0.5% 23,81 44 834 USD
2025-01-15 2025-01-13 A Achat

Roivant Sciences Ltd.

Administrateur non-exécutif Actionnaire important
16 845 010 +21.1%
20,00
336 900 200 USD 		16 845 010 +21.1% 20,00 336 900 200 USD
2025-01-10 2025-01-08 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
5 105 -0.5%
24,10
123 031 USD 		5 105 -0.5% 24,10 123 031 USD
2025-01-10 2025-01-08 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
4 105 -1.2%
24,10
98 931 USD 		4 105 -1.2% 24,10 98 931 USD
2024-12-04 2024-12-02 VP Vente planifiée

Hughes Douglas J.

Administrateur non-exécutif
5 425 -4.3%
28,54
154 830 USD 		5 425 -4.3% 28,54 154 830 USD
2024-12-04 2024-12-02 VP Vente planifiée

Pande Atul

Administrateur non-exécutif
7 750 -8.2%
28,54
221 185 USD 		7 750 -8.2% 28,54 221 185 USD
2024-11-22 2024-11-20 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
3 650 -1.1%
25,45
92 893 USD 		3 650 -1.1% 25,45 92 893 USD
2024-11-22 2024-11-20 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
3 353 -0.9%
25,45
85 334 USD 		3 353 -0.9% 25,45 85 334 USD
2024-11-22 2024-11-20 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
4 174 -1.2%
25,45
106 228 USD 		4 174 -1.2% 25,45 106 228 USD
2024-11-22 2024-11-20 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
16 692 -1.7%
25,45
424 811 USD 		16 692 -1.7% 25,45 424 811 USD
2024-10-25 2024-10-23 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
4 361 -1.3%
29,53
128 780 USD 		4 361 -1.3% 29,53 128 780 USD
2024-10-25 2024-10-23 V Vente

Stout Jay S

Chief Technology Officer

Dirigeant
2 740 -1.9%
29,53
80 912 USD 		2 740 -1.9% 29,53 80 912 USD
2024-10-25 2024-10-23 V Vente

Geffner Michael

Chief Medical Officer

Dirigeant
3 189 -2.3%
29,53
94 171 USD 		3 189 -2.3% 29,53 94 171 USD
2024-10-18 2024-10-16 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
561 -0.2%
28,79
16 151 USD 		561 -0.2% 28,79 16 151 USD
2024-10-18 2024-10-16 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
2 627 -0.7%
28,79
75 631 USD 		2 627 -0.7% 28,79 75 631 USD
2024-10-18 2024-10-16 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
9 095 -0.9%
28,79
261 845 USD 		9 095 -0.9% 28,79 261 845 USD
2024-10-18 2024-10-16 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
3 271 -1.0%
28,79
94 172 USD 		3 271 -1.0% 28,79 94 172 USD
2024-10-18 2024-10-16 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
2 860 -0.9%
28,79
82 339 USD 		2 860 -0.9% 28,79 82 339 USD
2024-10-11 2024-10-09 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
5 162 -1.5%
29,56
152 589 USD 		5 162 -1.5% 29,56 152 589 USD
2024-10-11 2024-10-09 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
4 460 -0.4%
29,56
131 838 USD 		4 460 -0.4% 29,56 131 838 USD
2024-08-23 2024-08-21 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
120 -0.0%
32,32
3 878 USD 		120 -0.0% 32,32 3 878 USD
2024-08-23 2024-08-21 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
2 907 -0.8%
31,84
92 559 USD 		2 907 -0.8% 31,84 92 559 USD
2024-08-23 2024-08-21 V Vente

Butchko Julia G.

Chief Development Officer

Dirigeant
120 -0.0%
32,32
3 878 USD 		120 -0.0% 32,32 3 878 USD
2024-08-23 2024-08-21 V Vente

Butchko Julia G.

Chief Development Officer

Dirigeant
2 907 -0.7%
31,84
92 559 USD 		2 907 -0.7% 31,84 92 559 USD
2024-08-23 2024-08-21 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
149 -0.0%
32,32
4 816 USD 		149 -0.0% 32,32 4 816 USD
2024-08-23 2024-08-21 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
3 619 -1.0%
31,84
115 229 USD 		3 619 -1.0% 31,84 115 229 USD
2024-08-23 2024-08-21 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
598 -0.1%
32,32
19 327 USD 		598 -0.1% 32,32 19 327 USD
2024-08-23 2024-08-21 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
14 470 -1.4%
31,84
460 725 USD 		14 470 -1.4% 31,84 460 725 USD
2024-08-23 2024-08-21 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
131 -0.0%
32,32
4 234 USD 		131 -0.0% 32,32 4 234 USD
2024-08-23 2024-08-21 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
3 164 -0.9%
31,84
100 742 USD 		3 164 -0.9% 31,84 100 742 USD
2024-07-26 2024-07-24 V Vente

Stout Jay S

Chief Technology Officer

Dirigeant
2 813 -1.9%
27,76
78 089 USD 		2 813 -1.9% 27,76 78 089 USD
2024-07-26 2024-07-24 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
4 015 -1.2%
27,76
111 456 USD 		4 015 -1.2% 27,76 111 456 USD
2024-07-26 2024-07-24 V Vente

Geffner Michael

Chief Medical Officer

Dirigeant
3 456 -2.4%
27,76
95 939 USD 		3 456 -2.4% 27,76 95 939 USD
2024-07-19 2024-07-17 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
31 -0.0%
30,55
947 USD 		31 -0.0% 30,55 947 USD
2024-07-19 2024-07-17 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
504 -0.1%
29,64
14 939 USD 		504 -0.1% 29,64 14 939 USD
2024-07-19 2024-07-17 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
147 -0.0%
30,55
4 491 USD 		147 -0.0% 30,55 4 491 USD
2024-07-19 2024-07-17 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
2 362 -0.6%
29,64
70 010 USD 		2 362 -0.6% 29,64 70 010 USD
2024-07-19 2024-07-17 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
510 -0.0%
30,55
15 581 USD 		510 -0.0% 30,55 15 581 USD
2024-07-19 2024-07-17 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
8 175 -0.8%
29,64
242 307 USD 		8 175 -0.8% 29,64 242 307 USD
2024-07-19 2024-07-17 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
147 -0.0%
30,55
4 491 USD 		147 -0.0% 30,55 4 491 USD
2024-07-19 2024-07-17 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
2 358 -0.7%
29,64
69 891 USD 		2 358 -0.7% 29,64 69 891 USD
2024-07-19 2024-07-17 V Vente

Butchko Julia G.

Chief Development Officer

Dirigeant
169 -0.0%
30,55
5 163 USD 		169 -0.0% 30,55 5 163 USD
2024-07-19 2024-07-17 V Vente

Butchko Julia G.

Chief Development Officer

Dirigeant
2 698 -0.6%
29,64
79 969 USD 		2 698 -0.6% 29,64 79 969 USD
2024-07-19 2024-07-17 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
184 -0.1%
30,55
5 621 USD 		184 -0.1% 30,55 5 621 USD
2024-07-19 2024-07-17 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
2 939 -0.8%
29,64
87 112 USD 		2 939 -0.8% 29,64 87 112 USD
2024-07-10 2024-07-09 V Vente

Butchko Julia G.

Chief Development Officer

Dirigeant
1 527 -0.3%
28,06
42 848 USD 		1 527 -0.3% 28,06 42 848 USD
2024-07-10 2024-07-09 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
4 747 -1.3%
28,06
133 201 USD 		4 747 -1.3% 28,06 133 201 USD
2024-07-10 2024-07-09 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
4 619 -0.4%
28,06
129 609 USD 		4 619 -0.4% 28,06 129 609 USD
2024-05-24 2024-05-22 V Vente

Macias William L.

Chief Medical Officer

Dirigeant
3 247 -0.9%
29,65
96 274 USD 		3 247 -0.9% 29,65 96 274 USD
2024-05-24 2024-05-22 V Vente

Butchko Julia G.

Chief Development Officer

Dirigeant
3 247 -0.7%
29,65
96 274 USD 		3 247 -0.7% 29,65 96 274 USD
2024-05-24 2024-05-22 V Vente

Barnett Eva Renee

Chief Financial Officer

Dirigeant
4 042 -1.1%
29,65
119 845 USD 		4 042 -1.1% 29,65 119 845 USD
2024-05-24 2024-05-22 V Vente

Salzmann Peter

Chief Executive Officer

Administrateur exécutif
16 163 -1.5%
29,65
479 233 USD 		16 163 -1.5% 29,65 479 233 USD
2024-05-24 2024-05-22 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
3 242 -0.9%
29,65
96 125 USD 		3 242 -0.9% 29,65 96 125 USD
2024-05-24 2024-05-22 V Vente

Levine Mark S.

Chief Legal Officer

Dirigeant
3 242 -0.9%
29,65
96 125 USD 		3 242 -0.9% 29,65 96 125 USD
// ... existing code ... // ... rest of the file ...